Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/201129
Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Purpose: To compare the effect of discontinuing bisphosphonate treatment on fracture risk in postmenopausal women at high versus low risk of fracture.Design: Retrospective, longitudinal and population-based cohort study.Setting: Barcelona City Primary Care. Catalan Health Institute. Participants: All women attended by primary care teams who in January 2014 had received bisphosphonate treatment for at least five years were included and followed for another five years.Intervention: Patients were classified according to their risk of new fractures, defined as those who had a history of osteoporotic fracture and/or who received treatment with an aromatase inhibitor, and the continuity or deprescription of the bisphosphonate treatment was analyzed over fiver year follow-up.Main measurements: The cumulative incidence of fractures and the incidence density were calculated and analyzed using logistic regression and Cox models.Results: We included 3680 women. There were no significant differences in fracture risk in high-risk women who discontinued versus continued bisphosphonate treatment (hazard ratio [HR] 1.17, 95% confidence interval [CI] 0.87--1.58 for total osteoporotic fractures). However, discontinuers at low risk had a lower incidence of fracture than continuers. This difference was significant for vertebral fractures (HR 0.64, 95% CI 0.47-0.88) and total fractures (HR 0.77, 95% CI 0.64-0.92).
Matèries
Matèries (anglès)
Citació
Citació
TRONCOSO MARIÑO, Amelia, LESTÓN VÁZQUEZ, Marta, GALLARDO BORGE, Sara, VAL GARCIA, José luís del, AMADO GUIRADO, Ester, VIOLÁN, Concepción. Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care. _Atención Primaria_. 2023. Vol. 55, núm. 7. [consulta: 10 de abril de 2026]. ISSN: 1578-1275. [Disponible a: https://hdl.handle.net/2445/201129]